MCF Advisors’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.9K Sell
7,404
-389
-5% -$2.44K ﹤0.01% 720
2026
Q1
$47.1K Hold
7,793
﹤0.01% 620
2025
Q4
$55.8K Buy
7,793
+237
+3% +$1.69K ﹤0.01% 489
2025
Q3
$57K Buy
7,556
+815
+12% +$5.95K ﹤0.01% 405
2025
Q2
$42.1K Hold
6,741
﹤0.01% 430
2025
Q1
$21K Hold
6,741
﹤0.01% 540
2024
Q4
$26.6K Buy
6,741
+741
+12% +$2.6K ﹤0.01% 498
2024
Q3
$24.3K Hold
6,000
﹤0.01% 509
2024
Q2
$15.3K Sell
6,000
-549
-8% -$1.82K ﹤0.01% 581
2024
Q1
$29.1K Buy
6,549
+3,000
+85% +$13K ﹤0.01% 467
2023
Q4
$16.8K Sell
3,549
-6,478
-65% -$27.7K ﹤0.01% 533
2023
Q3
$48.7K Hold
10,027
﹤0.01% 354
2023
Q2
$60.2K Buy
10,027
+977
+11% +$4.62K 0.01% 338
2023
Q1
$28.2K Hold
9,050
﹤0.01% 432
2022
Q4
$23.4K Hold
9,050
﹤0.01% 429
2022
Q3
$19K Buy
9,050
+3,000
+50% +$7.83K ﹤0.01% 463
2022
Q2
$16K Hold
6,050
﹤0.01% 465
2022
Q1
$16K Buy
+6,050
New +$19.8K ﹤0.01% 480

Other funds holding EVLV

MCF Advisors's EVLV Position: Q2 2026 in Review

MCF Advisors reduced its Evolv Technologies (EVLV) stake by 5% in Q2 2026, selling an estimated $2.44K and leaving 7,404 shares worth $42.9K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

MCF Advisors first reported a position in EVLV in Q1 2022 and has held it in 18 quarters since. The position peaked at $60.2K in Q2 2023. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • MCF Advisors held 7,404 shares of Evolv Technologies worth $42.9K as of Q2 2026.
  • MCF Advisors sold 389 Evolv Technologies shares in Q2 2026, an estimated $2.44K.
  • Evolv Technologies made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #720 holding.
  • MCF Advisors first reported a position in Evolv Technologies in Q1 2022 and has held it in 18 quarters since.
  • MCF Advisors's Evolv Technologies position peaked at $60.2K in Q2 2023.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.